Lehi, Utah — August 18, 2026
Weave Communications (NYSE: WEAV) is being taken private in an all-cash transaction valued at approximately $650 million. The deal, led by technology-focused private equity firm Francisco Partners, will pay stockholders $7.40 per share—a roughly 34% premium over the company’s closing price on August 17, 2026.
Pending stockholder and regulatory approvals, the transaction is expected to close in the fourth quarter of 2026. Following the close, Weave will delist from the NYSE, retain its brand name, and maintain its headquarters in Lehi, Utah.
While the immediate headlines spotlight the buyout premium, two deeper narratives define the move: a stark valuation recalibration from Weave’s public market high-water mark, and Francisco Partners’ aggressive assembly of an end-to-end healthcare technology stack.
The Financial Math: A Value Play in Vertical SaaS
The $650 million exit marks a steep decline from Weave’s market peak. On November 11, 2021, the day Weave rang the opening bell on the NYSE—without its co-founders—its stock hit an all-time high of $22.40, implying an equity valuation well above $1.4 billion. During that era of hyper-growth tech multiples, vertical SaaS companies frequently traded at 10x to 15x forward revenue.
Fast forward to 2026: Weave reported full-year 2025 revenue of $239 million (up 17% year-over-year) and first-quarter 2026 revenue of $65.5 million. At a $650 million price tag, Francisco Partners is acquiring Weave at roughly 2.7x trailing revenue.
This multiple reflects a broader public market re-rating of mid-cap software companies. Wall Street has increasingly penalized moderate-growth SaaS firms that sit in the awkward space between small-cap volatility and mega-cap scale. For Francisco Partners, picking up a sticky, specialized platform with steady 17% growth at sub-3x revenue represents a classic private equity value play: take a fundamental vertical engine private, optimize margins away from quarterly earnings pressure, and re-accelerate product innovation.
Francisco Partners’ Healthcare Rollup Strategy
To understand why Weave was an attractive target, one has to look at Francisco Partners’ surrounding portfolio.
The private equity giant has built a formidable healthcare ecosystem, most notably acquiring South Jordan-based AdvancedMD for $1.125 billion in late 2024 and carving out IBM’s Watson Health assets to launch Merative.
Francisco Partners
- Patient Comms & AI
- Billing & Payments
- Clinical Workflows
- Medical Billing
- Enterprise Insights
- Population Health
While Weave will continue to operate as an independent entity, the operational synergies across this portfolio are evident.
- Front-Office to Back-Office Integration: Weave sits directly at the point of patient contact—handling phone systems, text reminders, review generation, and front-desk payments for more than 40,000 practice locations. AdvancedMD, meanwhile, powers deep clinical workflows, electronic health records (EHR), and backend medical billing.
- The Unified Workflow: By pairing Weave’s patient-facing engagement layers with practice management engines like AdvancedMD, Francisco Partners can build seamless, cross-platform integrations that traditional point solutions struggle to match.
- Data-Driven Practice Automation: Layering in data capabilities akin to Merative gives independent dental, optometry, veterinary, and medical practices access to enterprise-grade analytics that streamline practice operations and patient retention.
Executive Insights
"Since our founding in 2008, we have built Weave for a customer most software companies overlook — the independent practices that care for patients in communities across the country," said Brett White, CEO of Weave. "Together with Francisco Partners, we will be able to enhance our ability to invest in our AI platform, deepen our payments and revenue cycle management capabilities, and further our vision of a better healthcare experience at every practice."

Stuart C. Harvey Jr., Chair of Weave's Board of Directors, emphasized the board's evaluation process: "The Weave Board conducted a thorough evaluation of strategic alternatives and spoke with a number of strategic and financial parties. The transaction with Francisco Partners delivers a substantial premium and compelling, certain cash value to our stockholders."
Speaking to the strategic fit, Ezra Perlman, Co-President at Francisco Partners, noted Weave's market position: "Its vertical platform sits at the center of how tens of thousands of practices communicate with their patients and collect revenue, a position that is difficult to build and harder still to replicate."
Key Deal Metrics
| Metric | IPO Peak (Nov 2021) | Buyout Agreement (Aug 2026) |
| Share Price | $22.40 | $7.40 |
| Transaction Value | ~$1.4B+ | ~$650 Million |
| Implied Revenue Multiple | ~12x+ | ~2.7x |
| Market Status | Public (NYSE: WEAV) | Private (Francisco Partners Portfolio) |